Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
MYLAN PHARMACEUTICALS INC. v. WARNER CHILCOTT PUBLIC LIMITED COMPANY et al
Case Number:
2:12-cv-03824
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Baker & Hostetler
- Ballard Spahr
- Berger Montague
- Bolognese & Associates
- Buchanan Ingersoll
- Cafferty Clobes
- Clark Hill
- Faruqi & Faruqi
- Grabar Law
- Grant & Eisenhofer
- Hagens Berman
- Hilliard & Shadowen
- Korein Tillery
- Littler Mendelson
- Massey & Gail
- McCarter & English
- Radice Law Firm
- Reed Smith
- Schnader Harrison
- Sheppard Mullin
- Spector Roseman
- Sperling & Slater
- Stradley Ronon
- Taus Cebulash
- White & Case
- Wilson Sonsini
Companies
- Cardinal Health Inc.
- International Brotherhood of Electrical Workers
- Mayne Pharma Group Ltd.
- McKesson Corp.
- Rochester Drug Cooperative Inc.
- Safeway Inc.
- Supervalu Inc.
- Warner Chilcott Limited
Government Agencies
Sectors & Industries:
-
July 09, 2012
Mylan Accuses Warner, Mayne Of Plot To Delay Generics
Mylan Pharmaceuticals Inc. on Friday accused Warner Chilcott PLC and Mayne Pharma Group Ltd. of conspiring to prevent and delay generic competition to its anti-acne and bacterial infection drug Doryx by making minor changes to the drug every few years, with no real benefit.
- ← Previous
- 1
- 2
- Next →